Synthesis and Evaluation of Anti-Epileptic Properties of New Phthalimide-4,5-Dihydrothiazole-Amide Derivatives

References

• A. T. Sørensen, and M. Kokaia, “Novel Approaches to Epilepsy Treatment,” Epilepsia 54, no. 1 (2013): 1–10.
   PubMed Web of Science ®Google Scholar
• M. Itamar, A. Colson, D. Chisholm, T. Dua, A. Nandi, and R. Laxminarayan, “Health and Economic Benefits of Public Financing of Epilepsy Treatment in India: An Agent-Based Simulation Model,” Epilepsia 57, no. 3 (2016): 464–74.
   PubMed Web of Science ®Google Scholar
• M. James, J. R. Chapman, G. H. Cocolas, and I. H. Hall, “Hypolipidemic Activity of Phthalimide Derivatives. 1. N-Substituted Phthalimide Derivatives,” Journal of Medicinal Chemistry 22, no. 11 (1979): 1399–402.
   PubMed Web of Science ®Google Scholar
• L. M. Lima, P. Castro, A. L. Machado, C. A. M. Fraga, C. Lugnier, V. L. G. de Moraes, and E. J. Barreiro, “Synthesis and anti-Inflammatory Activity of Phthalimide Derivatives, Designed as New Thalidomide Analogues,” Bioorganic & Medicinal Chemistry 10, no. 9 (2002): 3067–73.
   PubMed Web of Science ®Google Scholar
• M. V. d. O. Cardoso, D. R. M. Moreira, G. B. Oliveira Filho, S. M. T. Cavalcanti, L. C. D. Coelho, J. W. P. Espíndola, L. R. Gonzalez, M. M. Rabello, M. Z. Hernandes, P. M. P. Ferreira, et al. “Design, Synthesis and Structure–Activity Relationship of Phthalimides Endowed with Dual Antiproliferative and Immunomodulatory Activities,” European Journal of Medicinal Chemistry 96 (2015): 491–503.
   PubMed Web of Science ®Google Scholar
• M. Iman, S. Fakhari, M. Jahanpanah, N. Naderi, and A. Davood, “Design and Synthesis of 4-Flurophthalimides as Potential Anticonvulsant Agents,” Iranian Journal of Pharmaceutical Research 17, no. 3 (2018): 896–905.
   PubMed Web of Science ®Google Scholar
• C. B. Mishra, S. Kumari, and M. Tiwari, “Thiazole: A Promising Heterocycle for the Development of Potent CNS Active Agents,” European Journal of Medicinal Chemistry 92 (2015): 1–34.
   PubMed Web of Science ®Google Scholar
• A. A. Siddiqui, S. Partap, S. Khisal, M. S. Yar, and R. Mishra, “Synthesis, Anti-Convulsant Activity and Molecular Docking Study of Novel Thiazole Pyridazinone Hybrid Analogues,” Bioorganic Chemistry 99 (2020): 103584.
   PubMed Web of Science ®Google Scholar
• M. R. Khajouei, A. Mohammadi-Farani, A. Moradi, and A. Aliabadi, “Synthesis and Evaluation of Anticonvulsant Activity of (Z)-4-(2-Oxoindolin-3-Ylideneamino)-N-Phenylbenzamide Derivatives in Mice,” Research in Pharmaceutical Sciences 13, no. 3 (2018): 262.
   PubMed Web of Science ®Google Scholar
• P. Ahuja, A. Husain, and N. Siddiqui, “Essential Aminoacid Incorporated GABA–Phthalimide Derivatives: Synthesis and Anticonvulsant Evaluation,” Medicinal Chemistry Research 23, 9 (2014): 4085–98.
   Web of Science ®Google Scholar
• A. Asadollahi, M. Asadi, F. S. Hosseini, Z. Ekhtiari, M. Biglar, and M. Amanlou, “Synthesis, Molecular Docking, and Antiepileptic Activity of Novel Phthalimide Derivatives Bearing Amino Acid Conjugated Anilines,” Research in Pharmaceutical Sciences 14, no. 6 (2019): 534.
   PubMed Web of Science ®Google Scholar
• P. K. Malaie, M. Asadi, F. S. Hosseini, M. Biglar, and M. Amanlou, “Synthesis, In Vivo and In Silico Studies of N-Aryl-4-(1, 3-Dioxoisoindolin-2-Yl) Benzamides as an Anticonvulsant Agent,” Pharmaceutical Sciences 26, no. 1 (2020): 38–44.
   Web of Science ®Google Scholar
• M. A. Bhat and M. A. Al-Omar, “Synthesis, Characterization and in Vivo Anticonvulsant and Neurotoxicity Screening of Schiff Bases of Phthalimide,” Acta Poloniae Pharmaceutica 68, no. 3 (2011): 375–80.
   PubMed Web of Science ®Google Scholar
• M. A. Bhat, M. A. Al-Omar, and N. Siddiqui, “Synthesis, Anticonvulsant and Neurotoxicity of Some Novel 1, 3, 4-Oxadiazole Derivatives of Phthalimide,” Der Pharma Chemica 2, no. 2 (2010): 1–10.
   Google Scholar
• G. M. Morris, R. Huey, W. Lindstrom, M. F. Sanner, R. K. Belew, D. S. Goodsell, and A. J. Olson, “AutoDock4 and AutoDockTools4: Automated Docking with Selective Receptor Flexibility,” Journal of Computational Chemistry 30, no. 16 (2009): 2785–91.
   PubMed Web of Science ®Google Scholar
• E. B. Bromfield, J. E. Cavazos, and J. I. Sirven, “Basic Mechanisms Underlying Seizures and Epilepsy,” in An Introduction to Epilepsy [Internet]. (West Hartford, CT: American Epilepsy Society, 2006).
   Google Scholar
• W. B. Wright, Jr., J. B. Press, P. S. Chan, J. W. Marsico, M. F. Haug, J. Lucas, J. Tauber, and A. S. Tomcufcik, “Thromboxane Synthetase Inhibitors and Antihypertensive Agents. 1. N-[(1H-Imidazol-1-yl)Alkyl]Aryl Amides and N-[(1H-1,2,4-Triazol-1-yl)Alkyl]Aryl Amides,” Journal of Medicinal Chemistry 29, no. 4 (1986): 523–30.
   PubMed Web of Science ®Google Scholar
• A. A. H. Abdel‐Rahman, O. M. Ali, and A. A. S. Abdel‐Megeed, “Synthesis and Antimicrobial Activity of New Tetrazoles Incorporating Isoindole‐1, 3‐Dione Moiety and Their Sugar Derivatives,” Journal of Heterocyclic Chemistry 50, no. 3 (2013): 484–9.
   Web of Science ®Google Scholar
• O. V. Maltsev, V. Walter, M. J. Brandl, and L. Hintermann, “Medium Buffer Effects on the Condensation of l-Cysteine and Aryl Nitriles to (R)-2-Aryl-4, 5-Dihydrothiazole-4-Carboxylic Acids,” Synthesis 45, no. 19 (2013): 2763–7.
   Web of Science ®Google Scholar
• L. A. Carpino, “1-Hydroxy-7-Azabenzotriazole. An Efficient Peptide Coupling Additive,” Journal of the American Chemical Society 115, no. 10 (1993): 4397–8.
   Web of Science ®Google Scholar
• L. Richter, C. De Graaf, W. Sieghart, Z. Varagic, M. Mörzinger, I. J. De Esch, G. F. Ecker, and M. Ernst, “Diazepam-Bound GABAA Receptor Models Identify New Benzodiazepine Binding-Site Ligands,” Nature Chemical Biology 8, no. 5 (2012): 455–64.
   PubMed Web of Science ®Google Scholar
• B. Frølund, L. S. Jensen, L. Guandalini, C. Canillo, H. T. Vestergaard, U. Kristiansen, B. Nielsen, T. B. Stensbøl, C. Madsen, P. Krogsgaard-Larsen, et al. “Potent 4-Aryl- or 4-Arylalkyl-Substituted 3-Isoxazolol GABA(A) Antagonists: Synthesis, Pharmacology, and Molecular Modeling,”Journal of Medicinal Chemistry 48, no. 2 (2005): 427–39.
   PubMed Web of Science ®Google Scholar
• L. L. C. Schrodinger, “The PyMOL Molecular Graphics System.” Version 1, no. 5 (2010): 0.
   Google Scholar
• G. Palencia, A. Calderon, and J. Sotelo, “Thalidomide Inhibits Pentylenetetrazole-Induced Seizures,” Journal of the Neurological Sciences 258, no. 1–2 (2007): 128–31.
   PubMed Web of Science ®Google Scholar
• L. Giot, J. S. Bader, C. Brouwer, A. Chaudhuri, B. Kuang, Y. Li, Y. L. Hao, C. E. Ooi, B. Godwin, E. Vitols, et al. “A Protein Interaction Map of Drosophila melanogaster,” Science (New York, NY) 302, no. 5651 (2003): 1727–36.
   Google Scholar